Updated Mar 13, 2018

House votes today on controversial "right to try" bill

Energy and Commerce Committee Chairman Greg Walden. (Photo: Drew Angerer / Getty Images)

The House will vote today on a bill that would expand terminally ill patients' access to medical products that are still being reviewed by the Food and Drug Administration. Most Democrats are still expected to oppose it.

Why this matters: Access to these experimental medicines could give one last option to people with none left, although it's unclear how many doctors, drug makers and patients would take advantage of this new option.

The details: The so-called "right to try" bill would let terminally ill patients buy unapproved treatments. Critics had long been wary that such a step could undermine the rigorous clinical trials the FDA uses to approve or reject new treatments. But a revised bill released over the weekend includes some significant changes designed to address those concerns.

  • The definition of eligible patients was narrowed.
  • Informed consent requirements were strengthened and reporting requirements for side effects were tightened.
  • The FDA was given more flexibility to determine how "right to try" uses will impact a drug's approval.
  • It equalizes liability for doctors and drug makers under both right to try and an existing pathway to use experimental drugs, to avoid incentivizing one over the other.

Between the lines: FDA Commissioner Scott Gottlieb outlined a set of patient protections when he testified on right to try before Congress in the fall. All of them were included rrein this version of the bill.

Yet, but: Rep. Frank Pallone, the top Democrat on the House Energy and Commerce Committee, came out yesterday with a strong statement against the bill, saying it "puts vulnerable patients at risk by completely removing the Food and Drug Administration from the review or oversight of access to investigational therapies."

  • "This legislation simply is not needed," he added, citing an existing program that gives patients the ability to use an unapproved medication outside of a clinical trial.
  • Supporters point out that products must have cleared several steps of the FDA approval process before they can be accessed through "right to try."

The big question is how much use right to try will get. Although many states have their own laws allowing it, takers have been limited.

  • On the other hand, there's an argument to be made that because federal law preempts state law when it comes to regulation of medicine, doctors and drug makers have been slow to take advantage of state right to try laws because they're afraid of legal consequences.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 4:30 p.m. ET: 1,083,084 — Total deaths: 58,243 — Total recoveries: 225,422Map.
  2. U.S.: Total confirmed cases as of 4:30 p.m. ET: 266,671 — Total deaths: 6,921 — Total recoveries: 9,445Map.
  3. 2020 latest: Wisconsin governor calls for last-minute primary election delay.
  4. Oil latest: The amount of gasoline American drivers are consuming dropped to levels not seen in more than 25 years, government data shows.
  5. Business updates: America's small business bailout is off to a bad start.
  6. U.S.S. Theodore Roosevelt: Senators call for independent investigation into firing of Navy captain.
  7. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

America's small business bailout is off to a bad start

Illustration: Sarah Grillo/Axios

Websites have crashed, phones are jammed and confusion reigns as businesses rushed at today's kickoff to get their chunk of the $350 billion Paycheck Protection Program.

Why it matters: This is a race to save jobs in the present and the future, and to ensure that as many workers as possible keep their benefits and paychecks during the coronavirus lockdown.

Go deeperArrow38 mins ago - Health

Coronavirus fuels historic drop in gasoline demand

Reproduced from EIA; Chart: Axios Visuals

The amount of gasoline American drivers are consuming dropped to levels not seen in more than 25 years, government data shows.

Driving the news: When most of us are staying home and not driving, this is one of the most predictable—but nonetheless still staggering—upshots of the unfolding coronavirus crisis.